Feb 18, 2021
An FDA warning over pharma company's promo material; Entresto's approval is expanded, There’s approvals in homozygous familial hypercholesterolemia and chronic inflammatory demyelinating polyneuropathy; And a migraine device for OK'd for teens.
Feb 12, 2021
This week’s stories include a caution about remdesivir; New and updated Emergency Use Authorizations; And new approvals in sleep apnea and for Botox.
Feb 5, 2021
This week we take a look at the remaining prospective COVID vaccines, that includes AstraZeneca, J&J and Novovax; There’s also drug approvals for analgesia and influenza.